Sunday 8 November 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
2
Average plausibility
84%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
01PoliticsGlobal

Australia’s fossil fuel role draws scrutiny ahead of UN climate talks

Reports establish a credibility debate over Australia’s coal and gas role, but not whether it will undermine climate negotiations.

The Guardian reports that Climate Change Minister Chris Bowen has dismissed concerns about Australia’s ability to help countries move away from fossil fuels while remaining a major producer and exporter. AAP and The Age also describe criticism of Australia’s climate leadership ahead of COP31, while UN human rights experts and Amnesty International have urged stronger action at home. The supplied coverage describes pressure on Australia, not a negotiating outcome.

What holds up

  • ✓The Guardian and The Age both identify Bowen as Australia’s climate change minister and describe the tension between his negotiating role and Australia’s fossil fuel exports. AAP also reports concerns about the country’s reliance on those exports.
  • ✓The criticism is documented, not merely hypothetical: an official UN human rights statement calls for Australia’s international leadership to match stronger domestic climate action, and Amnesty’s own statement challenges continued coal and gas expansion.

What doesn't yet

  • ?Only The Guardian excerpt reports Bowen dismissing these concerns, without supplying his full remarks. The snippets are not full-article verification and do not show how he answered the criticism.
  • ?Warnings that Australia cannot credibly lead are judgments by advocates and experts, not proof that negotiations will fail. Amnesty makes that judgment directly; AAP and The Age report similar criticism rather than establishing its predicted effect.
  • ?Only three outside newsrooms are used here, so source breadth is limited and other accounts may be missing. Statements from advocacy groups and UN experts establish what those speakers said; they do not add separate newsroom confirmation of every underlying claim.

Ask before you share

  • →What did Bowen say in full, and what commitments did he offer to address concerns about Australia’s coal and gas exports?
  • →Do other governments say Australia’s fossil fuel policies are affecting negotiations, or is the available criticism mainly from advocates and experts?
  • →What eventual negotiating text or commitments would show whether Australia helped strengthen or weaken the transition away from fossil fuels?

Sources & original reporting

  1. [1]The Guardian · Published 7 Nov 2026 · theguardian.com
  2. [2]Amnesty · Published 8 Nov 2026 · amnesty.org.au
  3. [3]Aapnews Aap · Published 6 Nov 2026 · aapnews.aap.com.au
  4. [4]Ohchr · Published 5 Nov 2026 · ohchr.org
  5. [5]Theage · Published 7 Nov 2026 · theage.com.au
02HealthGlobal

Ebola research highlights vaccine gap for Bundibugyo strain

Recent reports support the lack of a licensed Bundibugyo vaccine, but promising research has not yet established protection against the virus.

DW reports that Bundibugyo Ebola is causing a current outbreak and that new research raises hopes for broader vaccine protection. A recent MSF brief places the outbreak response in the Democratic Republic of the Congo and says no vaccine is licensed specifically for Bundibugyo. MSF says researchers are testing existing Ebola vaccines and new candidates, but protection from Ervebo against Bundibugyo remains unproven.

What holds up

  • ✓DW and MSF both describe a current Bundibugyo outbreak. MSF's recent brief also supports the central vaccine gap, with the more precise wording that no vaccine is licensed specifically for Bundibugyo.
  • ✓Research is underway, rather than merely proposed: MSF names the BRAVO study and Tumaini trial. As background, a July ANRS account reports that samples from people vaccinated against Zaire Ebola contained antibodies against Bundibugyo, while explicitly warning that this does not demonstrate clinical protection.

What doesn't yet

  • ?DW's wording that there is “no vaccine” is too broad without qualification. Candidates exist, and MSF says the DRC is using Ervebo, but its effectiveness against Bundibugyo remains unproven.
  • ?The supplied DW excerpt does not identify the research behind its optimism or provide methods or results. The older antibody findings offer a reason to investigate, not evidence that a vaccine protects people against several Ebola types.
  • ?Only a few outside newsrooms are represented in the evidence used here, so other accounts may be missing. ReliefWeb repeats the MSF brief rather than providing a separate reporting check; MSF also leads one of the studies. These excerpts are not full-article verification.

Ask before you share

  • →Which study does DW mean, and did it measure antibodies, illness prevention, or another outcome?
  • →Have trials shown that Ervebo or a Bundibugyo-specific candidate prevents disease, and what safety and effectiveness results are available?
  • →Does “no vaccine” mean no licensed Bundibugyo vaccine, rather than no experimental options or vaccines being tested for protection?

Sources & original reporting

  1. [1]DW · Published 7 Nov 2026 · dw.com
  2. [2]Reliefweb · Published 2 Nov 2026 · reliefweb.int
  3. [3]Msfaccess · Published 27 Oct 2026 · msfaccess.org
  4. [4]Anrs · Published 24 Jul 2026 · anrs.fr